Cargando…
Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury
INTRODUCTION: The aim of this study was to assess the efficacy of arginine-vasopressin (AVP) as a rescue therapy in catecholamine-refractory septic and non-septic shock in extremely low birth weight (ELBW) infants with acute renal injury. METHODS: Prospective assessment of AVP therapy in three ELBW...
Autores principales: | Meyer, Sascha, Gottschling, Sven, Baghai, Ali, Wurm, Donald, Gortner, Ludwig |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550969/ https://www.ncbi.nlm.nih.gov/pubmed/16677425 http://dx.doi.org/10.1186/cc4917 |
Ejemplares similares
-
The effect of vasopressin on gastric perfusion in catecholamine-dependent septic shock patients
por: van Haren, FMP, et al.
Publicado: (2003) -
Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009) -
Use of vasopressin in the treatment of refractory septic
shock
por: Kny, Katiuce Tomazi, et al.
Publicado: (2018) -
Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort
por: Myc, Lukasz A, et al.
Publicado: (2017) -
Efficacy and Safety of Vasopressin Alone or in Combination With Catecholamines in the Treatment of Septic Shock: A Systematic Review
por: Mandal, Naishal, et al.
Publicado: (2022)